Thrombin activation of endometrial endothelial cells: A possible role in intrauterine growth restriction

Summary

Preeclampsia (PE), intrauterine growth restriction (IUGR) and abruption with or without fetal loss are associated with reduced uteroplacental blood flow, decidual vasculopathy, endothelial cell dysfunction, thrombosis, inflammation and hemorrhage. Our hypothesis is that reduced uteroplacental blood flow causes focal decidual hypoxia that generates vascular endothelial growth factor (VEGF). The latter acts directly on decidual endothelial cells to induce aberrant expression of tissue factor (TF), the primary initiator of coagulation. This in turn generates thrombin that induces: i) further TF expression; and ii) inflammatory cytokines. BothVEGF and TF induce aberrant angiogenesis-vessel maintenance reflected by endothelial cell fenestrations and induction of a prothrombotic surface causing both the decidual hemorrhage (i.e.abruption) and thrombosis (i.e.uteroplacental vascular insuf- ficiency) observed in these adverse pregnancy outcomes. This novel hypothesis is supported by our finding of TF expression in decidual endothelium of pregnancies complicated by IUGR and/ or fetal loss. Moreover, treatment of cultured endometrial endothelial cells with VEGF or thrombin induces TF protein and mRNA expression. Quantitative RT-PCR analysis indicates that thrombin enhances (>10-fold) the output of diverse inflammatory cytokines in these cultures. The greatest effect (>2-log) was seen on macrophage inflammatory protein 3 α (MIP3 α ). In vitro, thrombin results in endometrial endothelial cell aggregations and changes in the apoptotic pathway. Thus, we postulate that reductions in uteroplacental flow initiate a cascade of molecular effects leading to hypoxia, thrombosis, inflammation, and endothelial cell dysfunction resulting in untoward pregnancy outcomes.

Keywords

Angiogenesis and inhibitors - pregnancy - inflammation - haemostasis - cytokines

• References

• 1 Jaffe R. Investigation of abnormal first-trimester gestations by color Doppler Imaging. J Clin Ultrasound 1993; 21: 521-526.
• 2 Zeek PM, Assali NS. Vascular changes in the decidua associated with eclamptogenic toxaemia of pregnancy. Am J Clin Pathol 1950; 20: 1099-1109.
• 3 Sheppard BL, Bonnar J. An ultrastructural study of utero-placental spiral arteries in hypertensive and normotensive pregnancy and fetal growth retardation. Br J Obstet Gynaecol 1981; 88: 695-705.
• 4 Rodesch F, Simon P, Donner C. et al. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 1992; 80: 283-285.
• 5 Vandenbosche RC, Kirchner JT. Intrauterine growth retardation. Am Fam Physician 1998; 58: 1384-1390 , 1393–1394.
• 6 Barker DJP. Mothers, Babies, and Disease in Later Life. BMJ Publishing Group; London, UK: 1994
• 7 Nathanielsz PW. Life In The Womb: The Origin of Health and Disease. Promethean Press. Edmonds; Wash: 1999
• 8 Rich-Edwards JW, Stampfer MJ, Manson JE. et al. Birthweight and risk of cardiovascular disease in a cohort of women followed up since 1976. Br Med J 1997; 315: 396-400.
• 9 Kingdom JC, Kaufmann P. Oxygen and placental villous development: origins of fetal hypoxia. Placenta 1997; 18: 613-621.
• 10 Salafia CM, Ernst LM, Pezzullo JC. et al. The very low birthweight infant: maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol 1995; 12: 106-110.
• 11 Lockwood CJ, Nemerson Y, Guller S. et al. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J Clin Endocrinol Metab 1993; 76: 231-236.
• 12 Runic R, Schatz F, Krey L. et al. Alterations in endometrial stromal cell tissue factor protein and messenger ribonucleic acid expression in patients experiencing abnormal uterine bleeding while using Norplant- 2 contraception. J Clin Endocrinol Metab 1997; 82: 1983-1988.
• 13 Lockwood CJ, Krikun G, Papp C. et al. The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation. Ann NY Acad Sci 1994; 734: 57-79.
• 14 Levi M, van der Poll T, ten Cate H. Tissue factor in infection and severe inflammation. Semin Thromb Hemost 2006; 32: 33-39.
• 15 Grau V, Stehling O, Garn H. et al. Accumulating monocytes in the vasculature of rat renal allografts: phenotype, cytokine, inducible no synthase, and tissue factor mRNA expression. Transplantation 2001; 71: 37-46.
• 16 Tilley R, Mackman N. Tissue factor in hemostasis and thrombosis. SeminThromb Hemost 2006; 32: 5-10.
• 17 Drake TA, Cheng J, Chang A. et al. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol 1993; 142: 1458-70.
• 18 Zhiwei Hu, Ying Sun, Alan Garen. Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model. Proceedings of the National Academy of Sciences 1999; 96: 8161-8166.
• 19 Thiruvikraman SV, Guha A, Roboz J. et al. In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest 1996; 75: 451-461.
• 20 Fei H, Berliner JA, Parhami F. et al. Regulation of endothelial cell tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler Thromb 1993; 13: 1711-1717.
• 21 Courtney MA, Haidaris PJ, Marder VJ. et al. Tissue factor mRNA expression in the endothelium of an intact umbilical vein. Blood 1996; 87: 174-179.
• 22 Holschermann H, Bohle RM, Zeller H. et al. In situ detection of tissue factor within the coronary intima in rat cardiac allograft vasculopathy. Am J Pathol 1999; 154: 211-220.
• 23 Stallmach T, Hebisch G, Orban P. et al. Aberrant positioning of trophoblast and lymphocytes in the fetomaternal interface with pre-eclampsia. Virchows Arch 1999; 434: 207-211.
• 24 Di Paolo S, Volpe P, Grandaliano G. et al. Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. J Nephrol 2003; 16: 650-657.
• 25 Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol 1996; 3: 379-384.
• 26 Shoji M, Hancock WW, Abe K. et al. Activation of coagulation and angiogenesis in cancer: immunohistochemcial localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol 1998; 152: 399-411.
• 27 Versteeg HH, Peppelenbosch MP, Spek CA. The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signaling?. Thromb Haemost 2001; 86: 1353-1359.
• 28 Peppelenbosch MP, Versteeg HH. Cell biology of tissue factor, an unusual member of the cytokine receptor family. Trends Cardiovasc Med 2001; 11: 335-339.
• 29 Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J. Biol Chem 1999; 274: 23969-23976.
• 30 Browder T, Folkman J, Pirie-Shepherd S. The hemostatic system as a regulator of angiogenesis. J Biol Chem 2000; 275: 1521-1524.
• 31 Senger DR, Ledbetter SR, Claffey KP. et al. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Am J Pathol 1996; 149: 293-305.
• 32 Maragoudakis ME, Tsopanoglou NE, Andriopoulou P. Mechanism of thrombin-induced angiogenesis. Biochem Soc Trans 2002; 30: 173-177.
• 33 Lockwood CJ, Krikun G, Koo AB. et al. Differential effects of thrombin and hypoxia on endometrial stromal and glandular epithelial cell vascular endothelial growth factor expression. J Clin Endocrinol Metab 2002; 87: 4280-4286.
• 34 Sharkey AM, Day K, McPherson A. et al. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. J Clin Endocrinol Metab 2000; 85: 402-409.
• 35 Salafia CM, Pezzullo JC, Charles AK. et al. Morphometry of the Basal plate superficial uteroplacental vasculature in normal midtrimester and at term. Pediatr Dev Pathol 2005; 8: 639-646.
• 36 Krikun G, Mor G, Huang J. et al. Metalloproteinase expression by control and telomerase immortalized human endometrial endothelial cells. Histol Histopathol 2005; 20: 719-724.
• 37 Bartha K, Brisson C, Archipoff G. et al. Thrombin regulates tissue factor and thrombomodulin mRNA levels and activities in human saphenous vein endothelial cells by distinct mechanisms. J Biol Chem 1993; 268: 421-429.
• 38 Mechtcheriakova D, Schabbauer G, Lucerna M. et al. Specificity, diversity, and convergence in VEGF and TNF-alpha signaling events leading to tissue factor upregulation via EGR-1 in endothelial cells. FASEB J 2001; 15: 230-242.
• 39 Krikun G, Sakkas D, Schatz F. et al. Endometrial angiopoietin expression and modulation by thrombin and steroid hormones: a mechanism for abnormal angiogenesis following long-term progestin-only contraception. Am J Pathol 2004; 164: 2101-2107.
• 40 Cakmak H, Schatz F, Huang ST. et al. Progestin suppresses thrombin-andinterleukin-1beta-induced interleukin-11 production in term decidual cells: implications for preterm delivery. J Clin Endocrinol Metab 2005; 90: 5279-5286.
• 41 Lockwood CJ, Nemerson Y, Krikun G. et al. Steroid-modulated stromal cell tissue factor expression: A model for the regulation of endometrial hemostasis and menstruation. J Clin Endo Metab 1993; 77: 1014-1019.
• 42 Thaloor D, Singh AK, Sidhu GS. et al. Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 1998; 9: 305-312.
• 43 Caunt M, Hu L, Tang T. et al. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Cancer Res 2006; 66: 4125-4132.
• 44 Huang Y-Q, Li J-J, Hu L. et al. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Thromb Haemost 2001; 86: 1094-1098.
• 45 Huang Y-Q, Hu L, Lee M. et al. Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood 2002; 99: 1646-50.
• 46 Haralabopoulos G, Grant D, Kleinman H. et al. Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivo. Am J Physiol 1997; 273: 239-45.
• 47 Herbert JM, Dupuy E, Laplace MC. et al. Thrombin induces endothelial cell growth via both a proteolytic and a non-proteolytic pathway. Biochem J 1994; 303: 227-231.
• 48 Caunt M, Huang Y, Brooks P. et al. Thrombin induces neoangiogenesis in the chick chorioallantoic membrane. J Thromb Haemost 2003; 1: 2078-80.
• 49 Meissner A, Zilles O, Varona R, et a. CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress. Blood 2003; 102: 2724-2727.
• 50 Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6 Cytokine Growth Factor Rev. 2003; 14: 409-426.
• 51 Lockwood CJ, Matta P, Krikun G. et al. Regulation of monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha and interleukin-1beta in first trimester human decidual cells: implications for preeclampsia. Am J Pathol 2006; 168: 445-452.
• 52 Renaud SJ, Postovit LM, Macdonald-Goodfellow SK. et al. Activated macrophages inhibit human cytotrophoblast invasiveness in vitro. Biol Reprod 2005; 73: 237-243.
• 53 Kinzler WL, Smulian JC, Kistler CA. et al. Extracellular matrix changes in the umbilical arteries of growth-restricted fetuses. Am J Obstet Gynecol 2005; 192: 1053-1059.
• 54 Tozzi CA, Christiansen DL, Poiani GJ. et al. Excess collagen in hypertensive pulmonary arteries decreases vascular distensibility. Am J Respir Crit Care Med 1994; 149: 1317-1326.
• 55 Riley DJ, Thakker-Varia S, Wilson FJ. et al. Role of proteolysis and apoptosis in regression of pulmonary vascular remodeling. Physiol Res 2000; 49: 577-585.
• 56 Mardi K, Sharma J. Histopathological evaluation of placentas in IUGR pregnancies. Indian J Pathol Microbiol 2003; 46: 551-554.